MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Article
MYCthroughmiR-17-92SuppressesSpeci cTargetGenestoMaintainSurvival,AutonomousProliferation,andaNeoplasticState
YulinLi,1PeterS.Choi,1StephanieC.Casey,1DavidL.Dill,2andDeanW.Felsher1,*
ofOncology,DepartmentofMedicineandPathology
ofComputerScience
StanfordUniversity,Stanford,CA94305,USA*Correspondence:dfelsher@stanford.edudoc.guandang.net
2Department1Division
CancerCell
SUMMARY
TheMYConcogeneregulatesgeneexpressionthroughmultiplemechanisms,anditsoverexpressionculmi-natesintumorigenesis.MYCinactivationreversesturmorigenesisthroughthelossofdistinguishingfeaturesofcancer,includingautonomousproliferationandsurvival.HerewereportthatMYCviamiR-17-92maintainsaneoplasticstatethroughthesuppressionofchromatinregulatorygenesSin3b,Hbp1,Suv420h1,andBtg1,aswellastheapoptosisregulatorBim.TheenforcedexpressionofmiR-17-92preventsMYCsuppressionfrominducingproliferativearrest,senescence,andapoptosisandabrogatessustainedtumorregression.Knockdownofthe vemiR-17-92targetgenesblockssenescenceandapoptosiswhileitmodestlydelaysproliferativearrest,thuspartiallyrecapitulatingmiR-17-92function.WeconcludethatMYC,viamiR-17-92,maintainsaneoplasticstatebysuppressingspeci ctargetgenes.
INTRODUCTION
Cancersareoftendependentonoraddictedtotheinitiatingon-cogenesforthemaintenanceofthemalignantphenotype(Chinetal.,1999;FelsherandBishop,1999;Huettneretal.,2000;Weinstein,2002).Theinactivationofasingledriveroncogenecanresultinrapidandsustainedtumorregression.Oncogeneaddictionhasbeenexploitedclinicallyintargetedtherapies,suchasimatinibforBCR-ABL-drivenchronicmyelogenousleukemia,ge tinibforlungadenocarcinomawithEGFRmuta-tions,andvemurafenibformelanomaswithB-RAFmutations(Chapmanetal.,2011;Drukeretal.,1996;LadanyiandPao,2008).Hence,thetargetedinactivationofoncogenesappearstobeageneralizableapproachforthetreatmentofmanycancers.
TheMYConcogeneisoverexpressedinoverhalfofhumancancers(Dang,2012).TostudytheroleofMYCintheinitiationandmaintenanceoftumorigenesis,someinvestigatorshave
usedthetetracyclineregulatorysystem(Tetsystem)togeneratereversiblemodelsofcancer(GossenandBujard,1992).Inthesemousemodels,theoverexpressionofaconditionalMYCtrans-geneinitiatestumorigenesis,anditsinactivationresultsinrapid,complete,andsustainedtumorregression.MYCinactivationisassociatedwiththelossofmanyofthedistinguishingfeaturesoftumorigenesisandresultsinproliferativearrest,apoptosis,differentiation,andsenescence,aswellastheshutdownofangiogenesis(D’Cruzetal.,2001;FelsherandBishop,1999;Ha-nahanandWeinberg,2011;Shachafetal.,2004;Wuetal.,2007).MYCisatranscriptionalregulatorofamultitudeofgenes,butitisunclearifanyofthesegenesareresponsibleforMYCmain-taininganeoplasticstate(Dang,2012).Recently,ithasbeenshownthatMYCmayregulategeneexpressionasageneraltranscriptionalampli er(Linetal.,2012;Nieetal.,2012).How-ever,ithasbeenpointedoutthatthiswouldnotexplainhowMYCcansuppressgeneexpressionorregulategeneexpressioninaspeci cmanner(Walzetal.,2013).MYChasalso

been

262CancerCell26,262–272,August11,2014ª2014ElsevierInc.
specific cell types and time miRNAs Regulating : ...Over-expression of TPM1 suppresses invasiveness of... Direct target of mir-21 through interactive of ...
Therapeutic microRNA delivery suppresses tumorigenesis...These findings suggest tissue- and tumor-specific ...through a noncanonical ILK target, JNK1, to the...
热门文档